{"protocolSection":{"identificationModule":{"nctId":"NCT05515419","orgStudyIdInfo":{"id":"101"},"organization":{"fullName":"The Medical Pavilion Bahamas","class":"OTHER"},"briefTitle":"Allogeneic Cord Blood for Neurological Diseases in Adults","officialTitle":"Allogeneic Cord Blood in the Treatment of Neurological Diseases in Adults"},"statusModule":{"statusVerifiedDate":"2023-11","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2024-01-03","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2024-09-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2024-11-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2022-08-18","studyFirstSubmitQcDate":"2022-08-24","studyFirstPostDateStruct":{"date":"2022-08-25","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-11-21","lastUpdatePostDateStruct":{"date":"2023-11-22","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"The Medical Pavilion Bahamas","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false,"isUsExport":false},"descriptionModule":{"briefSummary":"This open label trial is conducted to investigate the efficacy and safety of allogeneic umbilical cord blood therapy for adult patients with neurological diseases.","detailedDescription":"Neurological diseases such as stroke or spinal cord injuries are very common etiologies causing disability in developed countries. Cord blood possess various stem and progenitor cells, as well as their secreted regenerative factors, and is known to repair injured brain. The investigators clinical research aims to determine the safety and efficacy of allogeneic Umbilical Cord Blood for adult patients with neurological diseases such as stroke and spinal cord injury."},"conditionsModule":{"conditions":["Neurological Diseases","Stroke","Spinal Cord Injuries"],"keywords":["Adults"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["EARLY_PHASE1"],"designInfo":{"allocation":"NA","interventionModel":"SINGLE_GROUP","interventionModelDescription":"allogeneic cord blood for adult patients with neurological diseases","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":80,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Allogeneic cord blood therapy","type":"EXPERIMENTAL","description":"Allogeneic cord blood therapy","interventionNames":["Biological: Allogeneic cord blood treatment"]}],"interventions":[{"type":"BIOLOGICAL","name":"Allogeneic cord blood treatment","description":"Allogeneic cord blood treatment","armGroupLabels":["Allogeneic cord blood therapy"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Changes in modified Rankin Scale (mRS)","description":"modified Rankin Scale (mRS) from 1 - 5 whereby 1 is best (no significant disability) and 5 is worst (severe disability); The mRS is a commonly used scale for measuring the degree of disability or dependence in the daily activities of people who have suffered a stroke or other causes of neurological disability.","timeFrame":"1 month - 3 months - 6 months - 12 months"}],"secondaryOutcomes":[{"measure":"Monitoring Adverse Events","description":"Number of participants with treatment-related adverse events as assessedCommon by Toxicity Criteria for Adverse Events (CTCAE).version 5.0; adverse events are graded on a scale from 0 to 5, whereby grade 0 is best (no AE) and grade 5 is worst (fatal).","timeFrame":"1 month - 3 months - 6 months - 12 months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Ischemic or hemorrhagic stroke (onset \\< 24 months), or\n* Spinal cord injury (onset \\< 24 months)\n\nExclusion Criteria:\n\n* Raised intracranial pressure\n* Malignant cancer\n* Renal failure\n* Severe pulmonary dysfunction","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Conville S Brown, MD","role":"CONTACT","phone":"242-356-6666","phoneExt":"001","email":"drconvillebrown@gmail.com"},{"name":"Corrine S Quee, MD","role":"CONTACT","phone":"242-356-6666","phoneExt":"001","email":"support@tmp-bahamas.com"}],"overallOfficials":[{"name":"Conville S Brown, MD","affiliation":"The Medical Pavilion Bahamas","role":"PRINCIPAL_INVESTIGATOR"}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000013119","term":"Spinal Cord Injuries"},{"id":"D000009422","term":"Nervous System Diseases"}],"ancestors":[{"id":"D000013118","term":"Spinal Cord Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000020196","term":"Trauma, Nervous System"},{"id":"D000014947","term":"Wounds and Injuries"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M15606","name":"Spinal Cord Injuries","asFound":"Spinal Cord Injury","relevance":"HIGH"},{"id":"M15605","name":"Spinal Cord Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17375","name":"Wounds and Injuries","relevance":"LOW"},{"id":"M21713","name":"Trauma, Nervous System","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC26","name":"Wounds and Injuries"}]}},"hasResults":false}